![Amanda Hayward](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amanda Hayward
Presidente en Hoba Therapeutics ApS .
Perfil
Amanda Hayward is currently the Chairman at Hoba Therapeutics ApS.
Previously, she worked as a Director at Optherion, Inc., a Venture Partner at Connecticut Innovations, Inc., and the Chief Financial Officer at Renetx Bio, Inc. She also worked as a Senior Vice President at Scheer & Co., Inc. from 2000 to 2015.
Dr. Hayward holds a doctorate degree from Texas Tech University and an undergraduate degree from The University of Sheffield.
Cargos activos de Amanda Hayward
Empresas | Cargo | Inicio |
---|---|---|
Hoba Therapeutics ApS
![]() Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark. | Presidente | - |
Antiguos cargos conocidos de Amanda Hayward.
Empresas | Cargo | Fin |
---|---|---|
Scheer & Co., Inc.
![]() Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Analista de Capital Privado | 25/05/2010 |
Connecticut Innovations, Inc.
![]() Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Inversor de Capital Privado | - |
Renetx Bio, Inc.
![]() Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Director Financiero/CFO | - |
Optherion, Inc.
![]() Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Corporate Officer/Principal | - |
Formación de Amanda Hayward.
Texas Tech University | Doctorate Degree |
The University of Sheffield | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Scheer & Co., Inc.
![]() Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Finance |
Optherion, Inc.
![]() Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Health Technology |
Renetx Bio, Inc.
![]() Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Connecticut Innovations, Inc.
![]() Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Finance |
Hoba Therapeutics ApS
![]() Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Amanda Hayward